248 related articles for article (PubMed ID: 21136029)
41. Liver transplantation for hilar cholangiocarcinoma.
Thelen A; Neuhaus P
J Hepatobiliary Pancreat Surg; 2007; 14(5):469-75. PubMed ID: 17909715
[TBL] [Abstract][Full Text] [Related]
42. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
[TBL] [Abstract][Full Text] [Related]
43. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
44. A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Ren B; Guo Q; Yang Y; Liu L; Wei S; Chen W; Tian Y
Radiat Oncol; 2020 Jan; 15(1):15. PubMed ID: 31941520
[TBL] [Abstract][Full Text] [Related]
45. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.
Sasaki R; Takeda Y; Funato O; Nitta H; Kawamura H; Uesugi N; Sugai T; Wakabayashi G; Ohkohchi N
World J Surg; 2007 Sep; 31(9):1788-1796. PubMed ID: 17647056
[TBL] [Abstract][Full Text] [Related]
46. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
Vallis KA; Benjamin IS; Munro AJ; Adam A; Foster CS; Williamson RC; Kerr GR; Price P
Radiother Oncol; 1996 Oct; 41(1):61-6. PubMed ID: 8961369
[TBL] [Abstract][Full Text] [Related]
47. [Biliary tract carcinoma: surgery or irradiation?].
Terpstra OT
Ned Tijdschr Geneeskd; 1995 Jun; 139(22):1117-9. PubMed ID: 7540729
[No Abstract] [Full Text] [Related]
48. Postoperative chemoradiotherapy for extrahepatic bile duct cancer.
Park JH; Choi EK; Ahn SD; Lee SW; Song SY; Yoon SM; Kim YS; Lee YS; Lee SG; Hwang S; Lee YJ; Park KM; Kim TW; Chang HM; Lee JL; Kim JH
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):696-704. PubMed ID: 20510541
[TBL] [Abstract][Full Text] [Related]
49. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
[TBL] [Abstract][Full Text] [Related]
50. Photodynamic therapy in cholangiocarcinoma.
Kahaleh M
J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S44-7. PubMed ID: 23055215
[TBL] [Abstract][Full Text] [Related]
51. Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
Huang TW; Wang CH; Hsieh CB
Onkologie; 2007 Mar; 30(3):129-31. PubMed ID: 17341899
[TBL] [Abstract][Full Text] [Related]
52. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
53. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
54. Radiation therapy in cholangiocellular carcinomas.
Brunner TB; Seufferlein T
Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):593-602. PubMed ID: 27644907
[TBL] [Abstract][Full Text] [Related]
55. A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).
Itano O; Takemura Y; Kishida N; Tamagawa E; Shinozaki H; Ikeda K; Urakami H; Ei S; Hayatsu S; Suzuki K; Sakuragawa T; Ishii M; Shito M; Aiura K; Fujisaki H; Takano K; Matsui J; Minagawa T; Shinoda M; Kitago M; Abe Y; Yagi H; Oshima G; Hori S; Kitagawa Y
BMC Cancer; 2020 Jul; 20(1):688. PubMed ID: 32703191
[TBL] [Abstract][Full Text] [Related]
56. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic therapy for unresectable cholangiocarcinoma.
Tomizawa Y; Tian J
Dig Dis Sci; 2012 Feb; 57(2):274-83. PubMed ID: 22057285
[TBL] [Abstract][Full Text] [Related]
58. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
Hong JC; Jones CM; Duffy JP; Petrowsky H; Farmer DG; French S; Finn R; Durazo FA; Saab S; Tong MJ; Hiatt JR; Busuttil RW
Arch Surg; 2011 Jun; 146(6):683-9. PubMed ID: 21690444
[TBL] [Abstract][Full Text] [Related]
59. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
Nelson JW; Ghafoori AP; Willett CG; Tyler DS; Pappas TN; Clary BM; Hurwitz HI; Bendell JC; Morse MA; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):148-53. PubMed ID: 18805651
[TBL] [Abstract][Full Text] [Related]
60. Intraluminal Brachytherapy in Unresectable Extrahepatic Biliary Duct Cancer: An Italian Pooled Analysis.
Autorino R; Bisiello S; Pappalardi B; Privitera V; Buwenge M; Piccolo F; Masciocchi C; Tagliaferri L; Macchia G; Curti CD; Luppatteli M; Cerrotta A; Morganti AG; Valentini V; Mattiucci G
Anticancer Res; 2020 Jun; 40(6):3417-3421. PubMed ID: 32487639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
